INmune Bio surges ahead of key data readout
travellinglight/iStock via Getty Images
- It is slightly over a month ago that Biogen won the FDA approval for its Alzheimer’s disease drug Aduhelm (aducanumab).
- However, the company’s smaller rivals in the space have continued to outperform the broader market…
